As shown, for half of the patients from the ID-MUT study, the EGFR genotyping result was determined to be 6–7 cd (4–5 wd) after the tumor sampling with the IdyllaTM method, against 19–20 cd (13–14 wd) for the NGS method. The gene discussed is EGFR; the disease is neoplasm.